Canada's Largest Medical Cannabis Company to Discuss Strategy, Industry Trends, and Long-Term Growth Outlook EDMONTON, ALBERTA, Aug. 7, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, will participate in...
Related Questions
Is there any indication of upcoming productâpipeline expansions or regulatory milestones?
Will the conference provide guidance on revenue forecasts or EBITDA margins?
How will Aurora's participation in the conference affect investor sentiment toward ACB?
What specific strategic initiatives is Aurora likely to announce at the conference?
How might the disclosed longâterm growth outlook influence Aurora's capitalâallocation strategy?
What impact might any forwardâlooking statements have on the stock's valuation multiples?
Could the conference lead to a analyst reârating, and what priceâtarget adjustment might be expected?
How does Aurora's growth outlook compare to other Canadian medicalâcannabis peers such as Tilray and Cronos?
Could new partnerships or collaborations be revealed that might impact Aurora's market share?
Will the conference discussion address supplyâchain constraints or capacityâexpansion plans?